SMS Pharmaceuticals hits upper circuit on Dalal Street

23 Mar 2020 Evaluate
SMS Pharmaceuticals is currently trading at its upper circuit limit of Rs. 34.60, up by 5.75 points or 19.93% from its previous closing of Rs. 28.85 on the BSE.

The scrip opened at Rs. 30.45 and has touched a high and low of Rs. 34.60 and Rs. 27.90 respectively. So far 1968 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 67.50 on 01-Apr-2019 and a 52 week low of Rs. 23.55 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 34.60 and Rs. 26.95 respectively. The current market cap of the company is Rs. 253.96 crore.

The promoters holding in the company stood at 67.29%, while Institutions and Non-Institutions held 0.55% and 32.16% respectively.

SMS Pharmaceuticals has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its API facility situated at Kandivalasa, Andhra Pradesh. The USFDA had inspected the said facility during the period January 13, 2020 to January 17, 2020. This facility predominantly caters regulated markets including USA.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities.

SMS Pharmaceuticals Share Price

215.10 3.75 (1.77%)
24-Apr-2024 10:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1494.85
Dr. Reddys Lab 5980.90
Cipla 1380.20
Zydus Lifesciences 929.05
Lupin 1582.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.